Rating History for CTI BioPharma (CTIC) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/16/2023 | Kenneth Shields | Downgrade | Market Perform (Outperform) |
9.10 (13.00) |
8.96 (9.09) |
1.45% | Details |
